These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Relation between viremia and sero-antibodies to the anti-yellow fever vaccination of persons vaccinated with strain 17D-EP]. Santiago Actis A; Sa Fleitas MJ Rev Sanid Milit Argent; 1970; 69(1):51-63. PubMed ID: 5530987 [No Abstract] [Full Text] [Related]
5. WHO Expert Committee on Yellow Fever. Third report. World Health Organ Tech Rep Ser; 1971; 479():1-56. PubMed ID: 5003432 [No Abstract] [Full Text] [Related]
6. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476 [TBL] [Abstract][Full Text] [Related]
7. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? Barrett AD; Teuwen DE Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559 [TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. Collaborative Group for Studies with Yellow Fever Vaccine Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925 [TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic studies in vivo and in vitro after viral infections and after anti-yellow fever vaccination]. de Grouchy J; Tudela V; Feingold J Pathol Biol; 1967 Oct; 15(19):879-85. PubMed ID: 4869761 [No Abstract] [Full Text] [Related]
13. [Observations on the 17 D virus vaccine against yellow fever, applied by cutaneous scarification]. Groot H; Gast-Galvis A Rev Invest (Guadalajara); 1965 Apr; 5(1):5-25. PubMed ID: 5829925 [No Abstract] [Full Text] [Related]
14. [Comparison of 2 yellow fever vaccines administered by pressure injector without needle]. Gateff C; Robin Y; Labusquiere R; Le Gonidec G; Lemarinier G; Bradley M Med Trop (Mars); 1972; 32(2):193-7. PubMed ID: 5082185 [No Abstract] [Full Text] [Related]
15. [Simultaneous vaccination against hepatitis A and yellow fever]. Receveur MC; Quiniou JM; Delprat P; Monlun E; Lehner V; Le Bras M Bull Soc Pathol Exot; 1993; 86(5 Pt 2):406-9. PubMed ID: 7819790 [TBL] [Abstract][Full Text] [Related]
16. Yellow fever-associated viscerotropic disease in Barcelona, Spain. Muñoz J; Vilella A; Domingo C; Nicolas JM; de Ory F; Corachan M; Tenorio A; Gascon J J Travel Med; 2008; 15(3):202-5. PubMed ID: 18494699 [TBL] [Abstract][Full Text] [Related]
17. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination. Adu FD; Adeniji JA; Tomori O; Adelasoye A Rom J Virol; 1993; 44(1-2):3-7. PubMed ID: 9702244 [TBL] [Abstract][Full Text] [Related]
18. Lymphocytes and yellow fever. I. Transient virus refractory state following vaccination of man with the 17-D strain. Wheelock EF; Toy ST; Stjernholm RL J Immunol; 1970 Nov; 105(5):1304-6. PubMed ID: 5496134 [No Abstract] [Full Text] [Related]
19. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. Kengsakul K; Sathirapongsasuti K; Punyagupta S J Med Assoc Thai; 2002 Jan; 85(1):131-4. PubMed ID: 12075714 [TBL] [Abstract][Full Text] [Related]
20. [Is yellow fever a menace in Central Africa?]. Chippaux A; Chippaux-Hyppolite C Med Trop (Mars); 1966; 26(5):497-504. PubMed ID: 5976657 [No Abstract] [Full Text] [Related] [Next] [New Search]